Related references
Note: Only part of the references are listed.Crosstalk between ERK, AKT, and cell survival
Paul Dent
CANCER BIOLOGY & THERAPY (2014)
Targeting of the MET receptor tyrosine kinase by small molecule inhibitors leads to MET accumulation by impairing the receptor downregulation
Dominic Leiser et al.
FEBS LETTERS (2014)
Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion
Kazumasa Ohashi et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Systems biology for molecular life sciences and its impact in biomedicine
Miguel Angel Medina
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Lipika Goyal et al.
CLINICAL CANCER RESEARCH (2013)
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
Jennifer Vandooren et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Total Synthesis, Cytotoxic Effects of Damnacanthal, Nordamnacanthal and Related Anthraquinone Analogues
Muhammad Nadeem Akhtar et al.
MOLECULES (2013)
The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
Antonella De Luca et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells
Thararat Nualsanit et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Damnacanthal from the Congolese Medicinal Plant Garcinia huillensis has a Potent Preferential Cytotoxicity against Human Pancreatic Cancer PANC-1 Cells
Dya Fita Dibwe et al.
PHYTOTHERAPY RESEARCH (2012)
Anticancer Activity of Morinda citrifolia (Noni) Fruit: A Review
Amy C. Brown
PHYTOTHERAPY RESEARCH (2012)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
Targeting MET in cancer: rationale and progress
Ermanno Gherardi et al.
NATURE REVIEWS CANCER (2012)
Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways
Feng-Lang Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
c-Met Represents a Potential Therapeutic Target for Personalized Treatment in Hepatocellular Carcinoma
Hanning You et al.
HEPATOLOGY (2011)
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates
Ted L. Underiner et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis
Qian Qian et al.
CANCER INVESTIGATION (2010)
ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
Neru Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni)
Alison D. Pawlus et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Morinda citrifolia (Noni) fruit - Phytochemistry, pharmacology, safety
Olivier Potterat et al.
PLANTA MEDICA (2007)
Evaluation of the anti-angiogenic effect of aloe-emodin
C. Cardenas et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Antifungal anthraquinones from Saprosma fragrans
D. N. Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Targeting the c-Met signaling pathway in cancer
Benedetta Peruzzi et al.
CLINICAL CANCER RESEARCH (2006)
Biological activity of anthraquinones and triterpenoids from Prismatomeris fragrans
K Kanokmedhakul et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Natural anthraquinones probed as Type I and Type II photosensitizers:: singlet oxygen and superoxide anion production
SCN Montoya et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2005)
Homocysteine is a potent inhibitor of human tumor cell gelatinases
T Chavarría et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Share Paper
